Investors support new antifungal agent
Interviewee/Contributor
Ralf Schmid and Emma Harvey
Organisation
F2G Ltd
Finance
Pace of financing quickens for European biopharma
Interviewee/Contributor
Victoria English
Organisation
MedNous
Why private equity is investing in biopharma
Interviewee/Contributor
Emma Dabbs
Organisation
Novasecta Ltd
Three European biotechs raise nearly $6 billion
Interviewee/Contributor
Victoria English
Organisation
MedNous
Advanced therapy financing events in Q1 2019
Interviewee/Contributor
Victoria English
Organisation
MedNous
2018 Fourth quarter stock market review
Interviewee/Contributor
William Ellington
Organisation
MedNous
Light on the horizon for Swedish biopharma
Interviewee/Contributor
Søren Tulstrup
Organisation
Hansa Medical AB
Altheia Science Srl: Italian biotech raises $11 mln for autoimmunity
Interviewee/Contributor
MedNous financing article
Organisation
Altheia Science Srl
Pharma slow to adopt SE incorporation
Interviewee/Contributor
William Ellington
Organisation
MedNous
The case for optimism for Europe's biotech sector
Interviewee/Contributor
Robin Davison
Organisation
New Science Global Healthcare Fund